Duloxetine for the Treatment of Postpartum Depression

Conditions

Major Depressive Disorder | Postpartum Depression

What is the purpose of this trial?

The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.



Participation Guidelines

Age:
18 Years and older
Gender:
Female

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
July 2007
Last Updated:
July 8, 2014
Study HIC#:
0609001827

Clinicaltrials.gov ID: NCT00617045